References
- Kim YJ, Zhang D, Yang DC. Biosynthesis and biotechnological production of ginsenosides. Biotechnol Adv 2015;33:717-35. https://doi.org/10.1016/j.biotechadv.2015.03.001
- Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014;38:161-6. https://doi.org/10.1016/j.jgr.2014.03.001
- Lan TH, Xu ZW, Wang Z, Wu YL, Wu WK, Tan HM. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Biochem Pharmacol 2011;82:148-55.
- Ahmed T, Raza SH, Maryam A, Setzer WN, Braidy N, Nabavi SF, de Oliveira MR, Nabavi SM. Ginsenoside Rb1 as a neuroprotective agent: a review. Brain Res Bull 2016;125:30-43. https://doi.org/10.1016/j.brainresbull.2016.04.002
- Koh EJ, Kim KJ, Choi J, Jeon HJ, Seo MJ, Lee BY. Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat dietinduced obese zebrafish. J Ginseng Res 2017;41:23-30. https://doi.org/10.1016/j.jgr.2015.12.005
- Zhao BS, Liu Y, Gao XY, Zhai HQ, Guo JY, Wang XY. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signaling transduction factors in the NG108-15 murine neuroglial cell line. Molecules 2014;19:16925-36. https://doi.org/10.3390/molecules191016925
- Chen XJ, Zhang XJ, Shui YM, Wan JB, Gao JL. Anticancer activities of protopanaxadiol-and protopanaxatriol-type ginsenosides and their metabolites. Evid Based Complement Alternat Med 2016;2016.
- Xu FY, Shang WQ, Yu JJ, Sun Q, Li MQ, Sun JS. The antitumor activity study of ginsenosides and metabolites in lung cancer cell. Am J Transl Res 2016;8:1708-18.
- Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structureeactivity relationships, and molecular mechanisms of action. Front Pharmacol 2012;3:1-18.
- Choi JS, Chun KS, Kundu J, Kundu JK. Biochemical basis of cancer chemoprevenion and or chemotherapy with ginsenosides. Int J Mol Med 2013;32:1227-38. https://doi.org/10.3892/ijmm.2013.1519
- Nabavi SF, Sureda A, Habtemariam S, Nabavi SM. Ginsenoside Rd and ischemic stroke; a short review of literatures. J Ginseng Res 2015;39:299-303.
- Yang XD, Yang YY, Ouyang DS, Yang GP. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 2015;100:208-20. https://doi.org/10.1016/j.fitote.2014.11.019
- Jin X, Che DB, Zhang ZH, Yan HM, Jia ZY, Jia XB. Ginseng consumption and risk of cancer: a meta-analysis. J Ginseng Res 2015;40:269-77.
- WHO fact sheet. Cardiovascular diseases (CVDs) [Internet]. 2016 September [cited 2016 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/.
- Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10:4-18. https://doi.org/10.2174/157016112798829760
- Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013;2013:152786.
- Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol Appl Pharmacol 2010;246:171-83. https://doi.org/10.1016/j.taap.2010.05.008
- Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015;14:6. https://doi.org/10.1186/1475-2891-14-6
- Xu Z, Lan T, Wu W, Wu Y. The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine. J Vasc Surg 2011;53:156-64. https://doi.org/10.1016/j.jvs.2010.06.170
- Yu J, Eto M, Akishita M, Kaneko A, Ouchi Y, Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 2007;353:764-9.
- Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res 2010;31:158-75. https://doi.org/10.1097/BCR.0b013e3181c7ed82
- Kwok HH, Guo GL, Lau JK, Cheng YK, Wang JR, Jiang ZH, Keung MH, Mak NK, Yue PY, Wong RN. Stereoisomers ginsenosides-20(S)-Rg(3) and -20(R)-Rg(3) differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma. Biochem Pharmacol 2012;83:893-902. https://doi.org/10.1016/j.bcp.2011.12.039
- Chan LS, Yue PY, Mak NK, Wong RN. Role of MicroRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370-7. https://doi.org/10.1016/j.ejps.2009.08.008
- Duan Q, Yang L, Gong W, Chaugai S, Wang F, Chen C, Wang P, Zou MH, Wang DW. MicroRNA-214 is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis. J Cell Physiol 2015;230:1964-73.
- Kim JH. Cardiovascular aiseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res 2012;36:16-26. https://doi.org/10.5142/jgr.2012.36.1.16
- Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 2006;7:589-600. https://doi.org/10.1038/nrm1983
- Jiang QS, Hunag XN, Dai ZK, Yang GZ, Zhou QX, Shi JS, Wu Q. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat. J Ethnopharmacol 2007;111:567-72.
- Zhang YJ, Zhang XL, Li MH, Iqbal J, Bourantas CV, Li JJ, Su XY, Muramatsu T, Tian NL, Chen SL. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol 2013;62:50-7. https://doi.org/10.1097/FJC.0b013e31828f8d45
- Zhu D, Wu L, Li CR, Wang XW, Ma YJ, Zhong ZY, Zhao HB, Cui J, Xun SF, Huang XL, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009;108:117-24. https://doi.org/10.1002/jcb.22233
- Wang Y, Hu Z, Sun B, Xu J, Jiang J, Luo M. Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B-cell lymphoma/B-cell lymphoma-associated X protein pathway. Mol Med 2015;11:4518-24.
- Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 2011;38:4327-35. https://doi.org/10.1007/s11033-010-0558-4
- Sun Y, Liu Y, Chen K. Roles and mechanisms of ginsenoside on cardiovascular diseases: progress and perspectives. Sci China Life 2016;59:292-8.
- Huang J, Li LS, Yang DL, Gong QH, Deng J, Huang XN. Inhibitory effect of ginsenoside Rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation. Evid Based Complement Alternat Med 2012;2012:314395.
- Guo Y, Yang T, Lu J, Li S, Wan L, Long D, Li Q, Feng L, Li Y. Rb1 postconditioning attenuates liver warm ischemiaereperfusion injury through ROSeNOeHIF pathway. Life Sci 2011;88:598-605. https://doi.org/10.1016/j.lfs.2011.01.022
- Wong AS, Che CM, Leung KW. Recent advances in ginseng as cancer therapeutics: a functional andmechanistic overview. Nat Prod Rep 2015;32:256-72. https://doi.org/10.1039/C4NP00080C
- Lu P, Su W, Miao ZH, Niu HR, Liu J, Hua QL. Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chin J Integr Med 2008;14:33-6. https://doi.org/10.1007/s11655-007-9002-6
-
Wang L, Li X, Song YM, Wang B, Zhang FR, Yang R, Wang HQ, Zhang GJ. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to
$\gamma$ -radiation by targeting the nuclear factor-${\kappa}B$ pathway. Mol Med Rep 2015;12:609-14. https://doi.org/10.3892/mmr.2015.3397 - Shan X, Fu YS, Aziz F, Wang XQ, Yan Q, Liu JW. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLoS One 2014;9:e115401. https://doi.org/10.1371/journal.pone.0115401
- Lo YT, Tsai YH, Wu SJ, Chen JR, Chao JC. Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells. J Med Food 2011;14:1135-43. https://doi.org/10.1089/jmf.2010.1485
- Jiang JW, Chen XM, Chen XH, Zheng SS. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol 2011;17:3605-13. https://doi.org/10.3748/wjg.v17.i31.3605
- Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep 2012;5:1295-8.
- Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, et al. 20(S)-Ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des Devel Ther 2015;9:3969-87.
- Wu K, Li N, Sun H, Xu T, Jin F, Nie J. Endoplasmic reticulum stress activation mediates Ginseng Rg3-induced anti-gallbladder cancer cell activity. Biochem Biophys Res Commun 2015;466:369-75. https://doi.org/10.1016/j.bbrc.2015.09.030
- Lee CK, Park KK, Chung AS, Chung WY. Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem Toxicol 2012;50:2565-74. https://doi.org/10.1016/j.fct.2012.01.005
- Wang JH, Nao JF, Zhang M, He P. 20(S)-Ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumour Biol 2014;35:11985-94. https://doi.org/10.1007/s13277-014-2497-5
- Junmin S, Hongxiang L, Zhen L, Chao Y, Chaojie W. Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity. J Tradit Chin Med 2015;35:440-4. https://doi.org/10.1016/S0254-6272(15)30122-9
- He BC, Gao JL, Luo X, Luo J, Shen J, Wang L, Zhou Q, Wang YT, Luu HH, Haydon RC, et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling. Int J Oncol 2011;38:437-45.
- Leung KW, Cheung LW, Pon YL, Wong RN, Mak NK, Fan TP, Au SC, Tombran-Tink J, Wong AS. Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol 2007;152:207-15. https://doi.org/10.1038/sj.bjp.0707359
- Yu M, Yu X, Guo D, Yu B, Li L, Liao Q, Xing R. Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-b1-induced epithelial to mesenchymal transition in HepG2 cells. Mol Med Rep 2015;11:3167-73. https://doi.org/10.3892/mmr.2014.3098
- Steward W, Brown K. Cancer chemoprevention: a rapidly evolving field. Br J Cancer 2013;109:1-7. https://doi.org/10.1038/bjc.2013.280
- Stejskalova L, Pavek P. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 2011;12:715-30. https://doi.org/10.2174/138920111795470994
- Wang Y, Ye X, Ma Z, Liang Q, Lu B, Tan H, Xiao C, Zhang B, Gao Y. Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells. Eur J Pharmacol 2008;601:73-8. https://doi.org/10.1016/j.ejphar.2008.10.057
-
Li Y, Xiao Z, Li B, Liu K, Wang H, Qi J, Wang Y. Ginsenoside exhibits concentration-dependent dual effects on HepG2 cell proliferation via regulation of c-Myc and HNF-
$4{\alpha}$ . Eur J Pharmacol 2016;792:26-32. https://doi.org/10.1016/j.ejphar.2016.10.017 - WHO. Global report on diabetes. Geneva: WHO; 2016.
- Yuan HD, Kim JT, Kim SH, Chung SH. Ginseng and diabetes: the evidences from in vitro, animal and human studies. J Ginseng Res 2012;36:27-39. https://doi.org/10.5142/jgr.2012.36.1.27
- Hwang YP, Jeong HG. Ginsenoside Rb1 protects against 6-hydroxydopamineinduced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol 2010;242:18-28. https://doi.org/10.1016/j.taap.2009.09.009
- Shen L, Haas M, Wang DQ, May A, Lo CC, Obici S, Tso P, Woods SC, Liu M. Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats. Physiol Rep 2015;3:e12453.
- Xiong Y, Shen L, Liu KJ, Tso P, Xiong Y, Wang G, Woods SC, Liu M. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 2010;59:2505-12. https://doi.org/10.2337/db10-0315
- Kong HL, Wang JP, Li ZQ, Zhao SM, Dong J, Zhang WW. Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacol Sin 2009;30:396-403.
- Chen W, Wang J, Luo Y, Wang T, Li X, Li A, Li J, Liu K, Liu B. Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue. J Ginseng Res 2016;40:351-8. https://doi.org/10.1016/j.jgr.2015.11.002
- Lee HM, Lee OH, Kim KJ, Lee BY. Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells. Phytother Res 2012;26:1017-22. https://doi.org/10.1002/ptr.3686
- Kim SJ, Yuan HD, Chung SH. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. Biol Pharm Bull 2010;33:325-8. https://doi.org/10.1248/bpb.33.325
- Shang W, Yang Y, Zhou L, Jiang B, Jin H, Chen M. Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol 2008;198:561-9.
- Kim MJ, Koo YD, Kim M, Lim S, Park YJ, Chung SS, Jang HC, Park KS. Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis in C2C12 myotubes. Diabetes Metab J 2016;40:406-13. https://doi.org/10.4093/dmj.2016.40.5.406
- Lee OH, Lee HH, Kim JH, Lee BY. Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytother Res 2011;25:768-73. https://doi.org/10.1002/ptr.3322
- Kim KS, Jung Yang H, Lee IS, Kim KH, Park J, Jeong HS, Kim Y, Ahn KS, Na YC, Jang HJ. The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice. Sci Rep 2015;5:18325.
- Park MW, Ha J, Chung SH. 20(S)-Ginsenoside Rg3 enhances glucosestimulated insulin secretion and activates AMPK. Biol Pharm Bull 2008;31: 748-51. https://doi.org/10.1248/bpb.31.748
- Kim DY, Yuan HD, Huang B, Quan HY, Chung SH. Ginsenoside 20(R)-Rg3 stimulates glucose uptake in C2C12 myotubes via CaMKK-AMPK pathways. Food Sci Biotechnol 2010;19:1277-82. https://doi.org/10.1007/s10068-010-0182-z
- Yu H, Zhen J, Yang Y, Gu J, Wu S, Liu Q. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model. J Cell Mol Med 2016;20:623-31. https://doi.org/10.1111/jcmm.12739
- Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS, Lee BH, Lee JH, Pyo MK, Lee SM, Chung JM, et al. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res 2007;1136:190-9. https://doi.org/10.1016/j.brainres.2006.12.047
- Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K, Roller M, Stough C. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl) 2010;212:345-56. https://doi.org/10.1007/s00213-010-1964-y
- Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65-74. https://doi.org/10.2174/157015909787602823
- Skaper SD. The neurotrophin family of neurotrophic factors: an overview. Methods Mol Biol 2012;846:1-12.
- Zheng F, Wang H. NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons. Neurochem Int 2009;54:385-92. https://doi.org/10.1016/j.neuint.2009.01.006
- Liang W, Ge S, Yang L, Yang M, Ye Z, Yan M, Du J, Luo Z. Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures. Brain Res 2010;1357:19-25. https://doi.org/10.1016/j.brainres.2010.07.091
- Shi YQ, Huang TW, Chen LM, Pan XD, Zhang J, Zhu YG, Chen XC. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice. J Alzheimers Dis 2010;19:977-89. https://doi.org/10.3233/JAD-2010-1296
- Jiang B, Xiong Z, Yang J, Wang W, Wang Y, Hu ZL, Wang F, Chen JG. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol 2012;166:1872-87. https://doi.org/10.1111/j.1476-5381.2012.01902.x
- Ardah MT, Paleologou KE, Lv G, Menon SA, Abul Khair SB, Lu JH, Safieh-Garabedian B, Al-Hayani AA, Eliezer D, Li M, et al. Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiol Dis 2015;74:89-101.
- O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011;34:185-204. https://doi.org/10.1146/annurev-neuro-061010-113613
- Chen X, Huang T, Zhang J, Song J, Chen L, Zhu Y. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons. Brain Res 2008;1200:99-106.
- Shi C, Zheng DD, Fang L, Wu F, Kwong WH, Xu J. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Biochim Biophys Acta 2012;1820:453-60. https://doi.org/10.1016/j.bbagen.2011.12.005
-
Araki W. Post-translational regulation of the
${\beta}$ -secretase BACE1. Brain Res Bull 2016;126:170-7. https://doi.org/10.1016/j.brainresbull.2016.04.009 - Choi RJ, Roy A, Jung HJ, Ali MY, Min BS, Park CH, Yokozawa T, Fan TP, Choi JS, Jung HA. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides. J Ethnopharmacol 2016;190:219-30. https://doi.org/10.1016/j.jep.2016.06.013
- Chen LM, Lin ZY, Zhu YG, Lin N, Zhang J, Pan XD, Chen XC. Ginsenoside Rg1 attenuates beta-amyloid generation via suppressing PPARgamma-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol 2012;675:15-21. https://doi.org/10.1016/j.ejphar.2011.11.039
- Wu J, Pan Z, Cheng M, Shen Y, Yu H, Wang Q, Lou Y. Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GRdependent signaling pathway. Neurochem Int 2013;62:92-102. https://doi.org/10.1016/j.neuint.2012.09.016
- Liu J, He J, Huang L, Dou L, Wu S, Yuan Q. Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth. Neural Regen Res 2014;9:943-50. https://doi.org/10.4103/1673-5374.133137
- Hao K, Gong P, Sun SQ, Hao HP, Wang GJ, Dai Y, Liang Y, Xie L, Li FY. Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice. Eur J Pharmacol 2011;659:15-25. https://doi.org/10.1016/j.ejphar.2011.03.005
- Lau WS, Chan RY, Guo DA, Wong MS. Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol 2008;108:64-71. https://doi.org/10.1016/j.jsbmb.2007.06.005
- Shohami E, Biegon A. Novel approach to the role of NMDA receptors in traumatic brain injury. CNS Neurol Disord Drug Targets 2014;13:567-73. https://doi.org/10.2174/18715273113126660196
-
Zhang YF, Fan XJ, Li X, Peng LL, Wang GH, Ke KF, Jiang ZL. Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting
$Ca^{2+}$ influx through NMDA receptors and L-type voltage-dependent$Ca^{2+}$ channels. Eur J Pharmacol 2008;586:90-9. https://doi.org/10.1016/j.ejphar.2007.12.037 - Shen L, Zhang J. NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils. Neurol Res 2007;29:270-3. https://doi.org/10.1179/016164107X159144
- Yang L, Zhang J, Zheng K, Shen H, Chen X. Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice. J Gerontol A Biol Sci Med Sci 2014;69:282-94.
- Escobar CM, Krajewski SJ, Sandoval-Guzman T, Voytko ML, Rance NE. Neuropeptide Y gene expression is increased in the hypothalamus of older women. J Clin Endocrinol Metab 2004;89:2338-43. https://doi.org/10.1210/jc.2003-031899
- Gumbs MC, van den Heuvel JK, la Fleur SE. The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav 2016;162:161-73. https://doi.org/10.1016/j.physbeh.2016.04.049
- Lin N, Cai DL, Jin D, Chen Y, Shi JJ. Ginseng panaxoside Rb1 reduces body weight in diet-induced obese mice. Cell Biochem Biophys 2014;68:189-94. https://doi.org/10.1007/s12013-013-9688-3
- Ye J, Yao JP, Wang X, Zheng M, Li P, He C, Wan JB, Yao X, Su H. Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury. Mol Med Rep 2016;13:3083-91.
- Ni N, Liu Q, Ren H, Wu D, Luo C, Li P, Wan JB, Su H. Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury. Molecules 2014;19: 3012-24. https://doi.org/10.3390/molecules19033012
- Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011;13:184-90.
- Liu D, Zhang H, Gu W, Liu Y, Zhang M. Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3betamediated CHOP induction. Mol Med Rep 2014;9:1434-8. https://doi.org/10.3892/mmr.2014.1958
- Liu D, Zhang H, Gu W, Liu Y, Zhang M. Neuroprotective effects of ginsenoside Rb1 on high glucose-induced neurotoxicity in primary cultured rat hippocampal neurons. PLoS One 2013;8:e79399. https://doi.org/10.1371/journal.pone.0079399
Cited by
- Ginseng nanoparticles: a budding tool for cancer treatment vol.12, pp.10, 2018, https://doi.org/10.2217/nnm-2017-0070
- Plant Extracts and Phytochemicals Targeting α -Synuclein Aggregation in Parkinson's Disease Models vol.9, pp.None, 2018, https://doi.org/10.3389/fphar.2018.01555
- An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics vol.12, pp.3, 2018, https://doi.org/10.5582/bst.2018.01144
- Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca 2+ Levels via Cyclic Adenosine Monophosphate Dependent Manner vol.23, pp.4, 2018, https://doi.org/10.3746/pnf.2018.23.4.317
- Ginsenoside Rb1, A Major Saponin from Panax ginseng , Exerts Protective Effects Against Acetaminophen-Induced Hepatotoxicity in Mice vol.47, pp.8, 2018, https://doi.org/10.1142/s0192415x19500927
- Hetero-Tricyclic Lead Scaffold as Novel PDE5A Inhibitor for Antihypertensive Activity: In Silico Docking Studies vol.15, pp.4, 2019, https://doi.org/10.2174/1573409915666190214161221
- Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol vol.20, pp.1, 2019, https://doi.org/10.3390/ijms20010094
- Ginsenoside Rb1 Blocks Ritonavir-Induced Oxidative Stress and eNOS Downregulation through Activation of Estrogen Receptor-Beta and Upregulation of SOD in Human Endothelial Cells vol.20, pp.2, 2019, https://doi.org/10.3390/ijms20020294
- The Role of Herbal Bioactive Components in Mitochondria Function and Cancer Therapy vol.2019, pp.None, 2018, https://doi.org/10.1155/2019/3868354
- Efficacy and Mechanism of Panax Ginseng in Experimental Stroke vol.13, pp.None, 2018, https://doi.org/10.3389/fnins.2019.00294
- Gypenoside LXXV Promotes Cutaneous Wound Healing In Vivo by Enhancing Connective Tissue Growth Factor Levels Via the Glucocorticoid Receptor Pathway vol.24, pp.8, 2018, https://doi.org/10.3390/molecules24081595
- American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties vol.11, pp.5, 2018, https://doi.org/10.3390/nu11051041
- Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway vol.10, pp.5, 2019, https://doi.org/10.1039/c9fo00095j
- Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway vol.10, pp.5, 2019, https://doi.org/10.1039/c9fo00095j
- Arginyl-fructosyl-glucose, a Major Maillard Reaction Product of Red Ginseng, Attenuates Cisplatin-Induced Acute Kidney Injury by Regulating Nuclear Factor κB and Phosphatidylinositol 3-Kinase/Pr vol.67, pp.20, 2018, https://doi.org/10.1021/acs.jafc.9b00540
- Chemical Structures and Pharmacological Profiles of Ginseng Saponins vol.24, pp.13, 2018, https://doi.org/10.3390/molecules24132443
- Interspecies hybrids of Panax ginseng Meyer new line 0837 and Panax quinquefolius generated superior F1 hybrids with greater biomass and ginsenoside contents vol.60, pp.4, 2018, https://doi.org/10.1007/s13580-019-00154-4
- Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation vol.24, pp.23, 2019, https://doi.org/10.3390/molecules24234367
- Ginseng Gintonin Enhances Hyaluronic Acid and Collagen Release from Human Dermal Fibroblasts Through Lysophosphatidic Acid Receptor Interaction vol.24, pp.24, 2018, https://doi.org/10.3390/molecules24244438
- Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation vol.48, pp.7, 2020, https://doi.org/10.1142/s0192415x20500780
- A Critical Regulation of Th17 Cell Responses and Autoimmune Neuro-Inflammation by Ginsenoside Rg3 vol.10, pp.1, 2018, https://doi.org/10.3390/biom10010122
- Effect of Antioxidants on the Fibroblast Replicative Lifespan In Vitro vol.2020, pp.None, 2018, https://doi.org/10.1155/2020/6423783
- Strontium Modified Calcium Sulfate Hemihydrate Scaffold Incorporating Ginsenoside Rg1/Gelatin Microspheres for Bone Regeneration vol.8, pp.None, 2018, https://doi.org/10.3389/fbioe.2020.00888
- Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction from Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice through Regulating the PI3K/AKT/GSK-3 β and Bcl-2/ vol.2020, pp.None, 2018, https://doi.org/10.1155/2020/3707904
- Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells vol.10, pp.None, 2020, https://doi.org/10.3389/fphar.2019.01565
- Till 2018: a survey of biomolecular sequences in genus Panax vol.44, pp.1, 2018, https://doi.org/10.1016/j.jgr.2019.06.004
- Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts vol.10, pp.3, 2018, https://doi.org/10.3390/biom10030391
- Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled, Two-Armed Cross-Over Study vol.13, pp.3, 2018, https://doi.org/10.3390/ph13030045
- Biotechnological Interventions for Ginsenosides Production vol.10, pp.4, 2020, https://doi.org/10.3390/biom10040538
- Panax quinquefolium L. Ginsenosides from Hairy Root Cultures and Their Clones Exert Cytotoxic, Genotoxic and Pro-Apoptotic Activity towards Human Colon Adenocarcinoma Cell Line Caco-2 vol.25, pp.9, 2018, https://doi.org/10.3390/molecules25092262
- Ginsenoside Rg3 suppresses the growth of gemcitabine‐resistant pancreatic cancer cells by upregulating lncRNA‐CASC2 and activating PTEN signaling vol.34, pp.6, 2018, https://doi.org/10.1002/jbt.22480
- Characteristics of Panax ginseng Cultivars in Korea and China vol.25, pp.11, 2018, https://doi.org/10.3390/molecules25112635
- Taxane‐induced neurotoxicity: Pathophysiology and therapeutic perspectives vol.177, pp.14, 2018, https://doi.org/10.1111/bph.15086
- Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions vol.44, pp.4, 2018, https://doi.org/10.1016/j.jgr.2020.03.001
- The Advances on the Protective Effects of Ginsenosides on Myocardial Ischemia and Ischemia-Reperfusion Injury vol.20, pp.16, 2020, https://doi.org/10.2174/1389557520666200619115444
- Diversity of Ginsenoside Profiles Produced by Various Processing Technologies vol.25, pp.19, 2020, https://doi.org/10.3390/molecules25194390
- Effect of Korean Red Ginseng on Cholesterol Metabolites in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial vol.12, pp.11, 2018, https://doi.org/10.3390/nu12113423
- Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases vol.41, pp.1, 2018, https://doi.org/10.1002/med.21743
- The Effect of Shenyi Capsule on Non-Small-Cell Lung Cancer Combined with Chemotherapy from the Yin-Yang Perspective vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/1653750
- Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/8858006
- A Synergistic Anti-Diabetic Effect by Ginsenosides Rb1 and Rg3 through Adipogenic and Insulin Signaling Pathways in 3T3-L1 Cells vol.11, pp.4, 2021, https://doi.org/10.3390/app11041725
- Ginsenoside Rb1 attenuates microglia activation to improve spinal cord injury via microRNA‐130b‐5p/TLR4/NF‐κB axis vol.236, pp.3, 2018, https://doi.org/10.1002/jcp.30001
- Roles of plant‐derived bioactive compounds and related microRNAs in cancer therapy vol.35, pp.3, 2018, https://doi.org/10.1002/ptr.6883
- Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products vol.11, pp.3, 2018, https://doi.org/10.3390/biom11030467
- Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach vol.13, pp.6, 2018, https://doi.org/10.3390/cancers13061274
- Ginsenoside Rg3 Attenuates Early Hepatic Injury via Inhibiting PPARγ- and Ang II-Related Inflammation and Fibrosis in Type II Diabetic Mice vol.16, pp.4, 2018, https://doi.org/10.1177/1934578x211009691
- Bifunctional Self‐Powered Drug Delivery System to Promote the Release and Transdermal Delivery of Polar Molecules vol.6, pp.14, 2018, https://doi.org/10.1002/slct.202100835
- Neuroprotective Effect and Antioxidant Potency of Fermented Cultured Wild Ginseng Root Extracts of Panax ginseng C.A. Meyer in Mice vol.26, pp.10, 2021, https://doi.org/10.3390/molecules26103001
- Rg3-enriched Korean Red Ginseng extract inhibits blood-brain barrier disruption in an animal model of multiple sclerosis by modulating expression of NADPH oxidase 2 and 4 vol.45, pp.3, 2018, https://doi.org/10.1016/j.jgr.2020.09.001
- Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats vol.10, pp.6, 2021, https://doi.org/10.3390/plants10061132
- Pharmacological Efficacy of Ginseng against Respiratory Tract Infections vol.26, pp.13, 2018, https://doi.org/10.3390/molecules26134095
- Ginsenosides attenuate bioenergetics and morphology of mitochondria in cultured PC12 cells under the insult of amyloid beta-peptide vol.45, pp.4, 2018, https://doi.org/10.1016/j.jgr.2020.09.005
- Bioactive strontium ions/ginsenoside Rg1-incorporated biodegradable silk fibroin-gelatin scaffold promoted challenging osteoporotic bone regeneration vol.12, pp.None, 2018, https://doi.org/10.1016/j.mtbio.2021.100141
- Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics vol.14, pp.10, 2018, https://doi.org/10.3390/ph14101010
- Korean red ginseng alleviate depressive disorder by improving astrocyte gap junction function vol.281, pp.None, 2021, https://doi.org/10.1016/j.jep.2021.114466
- Determination of ginsenoside Rh3 in rat plasma by LC–MS/MS and its application to a pharmacokinetic study vol.36, pp.2, 2018, https://doi.org/10.1002/bmc.5268